Regenerative medicine has become a key focus worldwide, and the number of stem cell–based clinical trials are rapidly increasing every year. Yet, GMP-compliant and cost-effective stem cell manufacturing is still a major hurdle for clinical applications across the globe. In this webinar, we will present Miltenyi Biotec’s widely used CliniMACS Prodigy® Platform and MACSQuant® Family, which provide automated and GMP-compliant solutions for stem cell manufacturing, analyzing, and sorting.
You will learn:
Chao performed his PhD projects at the Chinese Academy of Sciences in Beijing, China, and then continued his Postdoc studies at the University of Bonn and the German Center for Neurodegenerative Diseases in Bonn, Germany, focusing on cell fate (re)programming. Chao joined Miltenyi Biotec as a Product Manager for the Regenerative Medicine portfolio in 2018. He and his colleagues are developing automated, closed, and scalable adherent stem cell cultivation technologies based on the widely used CliniMACS Prodigy® Cell Manufacturing Platform.
Access online courses anytime, anywhere.
Become an expert in standard and innovative applications.
Acquire broad expertise and a comprehensive skill set.